CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 15.019
EU - Europa 4.506
AS - Asia 2.969
OC - Oceania 16
AF - Africa 13
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.541
Nazione #
US - Stati Uniti d'America 15.006
CN - Cina 1.753
UA - Ucraina 1.451
IT - Italia 1.013
TR - Turchia 759
DE - Germania 664
GB - Regno Unito 501
SG - Singapore 356
FI - Finlandia 314
SE - Svezia 233
PL - Polonia 153
FR - Francia 89
ID - Indonesia 24
VN - Vietnam 19
IN - India 17
AU - Australia 14
CZ - Repubblica Ceca 14
BE - Belgio 13
CA - Canada 12
JP - Giappone 12
NL - Olanda 12
IE - Irlanda 10
RU - Federazione Russa 10
CH - Svizzera 8
EU - Europa 7
RO - Romania 7
IR - Iran 6
BR - Brasile 5
EG - Egitto 5
HK - Hong Kong 5
TW - Taiwan 5
HU - Ungheria 4
ES - Italia 3
IL - Israele 3
MA - Marocco 3
NO - Norvegia 3
AT - Austria 2
CO - Colombia 2
KR - Corea 2
MG - Madagascar 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 22.541
Città #
Fairfield 2.049
Woodbridge 1.907
Jacksonville 1.591
Houston 1.208
Chandler 1.143
Ashburn 883
Ann Arbor 861
Wilmington 761
Seattle 713
Cambridge 590
Izmir 530
Nanjing 526
Princeton 331
Beijing 229
Singapore 219
Washington 213
San Diego 175
Ferrara 152
Warsaw 152
Shenyang 143
Milan 140
Boardman 137
Nanchang 131
Hebei 101
Addison 87
Changsha 87
Jiaxing 87
Shanghai 74
New York 70
Dearborn 69
Tianjin 67
Jinan 56
Norwalk 46
Kunming 45
Redwood City 38
Zhengzhou 37
Falls Church 36
Mountain View 36
Ningbo 36
Verona 34
London 30
Rome 27
Taizhou 27
Bremen 25
Guangzhou 25
Orange 24
San Mateo 22
Los Angeles 20
Dong Ket 19
Helsinki 19
Jakarta 19
Augusta 17
Auburn Hills 16
Lanzhou 16
Catania 14
Changchun 14
Chicago 14
Brussels 13
Napoli 13
Pordenone 12
Philadelphia 11
Hangzhou 10
Naples 10
Tappahannock 10
Bologna 9
Indiana 9
Messina 9
Brno 8
Des Moines 8
Hefei 8
Munich 8
Padova 8
Parma 8
Torino 8
Vicenza 7
Düsseldorf 6
Leawood 6
Mumbai 6
Olomouc 6
Paris 6
Redmond 6
Turin 5
Aversa 4
Brescia 4
Budapest 4
Cagliari 4
Fontecchio 4
Kilburn 4
Kyoto 4
Lecco 4
Modena 4
Oristano 4
Taipei 4
Taiyuan 4
Walnut 4
Aci Catena 3
Anzano Del Parco 3
Baranello 3
Bari 3
Bolzano 3
Totale 16.415
Nome #
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 260
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 207
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 167
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 163
Sindrome epatopolmonare. 162
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 152
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 150
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 137
Models of infection and exacerbations in COPD. 130
Malattie polmonari primitive da cause dismetaboliche. 130
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 130
Definition, clinical features, investigations and differential diagnosis in asthma. 128
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 125
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 124
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects 123
null 121
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 120
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 119
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 118
null 118
Convergent sets of data from In Vivo and In Vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 117
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 117
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 116
Airway obstruction in chronic obstructive pulmonary disease. 115
null 114
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 114
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 111
null 111
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 109
COPD exacerbations: definitions and classifications 108
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 107
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 106
Allergen responses modified by a GATA3 DNAzyme 106
Clinical definition of COPD exacerbations and classification of their severity 105
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 105
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 105
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 105
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview 104
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 104
The level of control of mild asthma in general practice: An observational community-based study 104
The future of relievers and controllers in asthma therapy. 104
Therapies acting on transcription: overview. 104
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 103
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 103
A link between lung injury and inflammatory myopathies: making the diagnosis 103
null 102
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 101
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis 101
Chronic Obstructive pulmonary disease and lung cancer: New molecular insights 101
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 101
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 101
Mechanisms involved in lung cancer development in COPD 100
null 100
Extrapulmonary tuberculosis. 100
Chronic obstructive pulmonary disease international guidelines. 99
null 98
Strategies for improving the efficacy and therapeutic ratio of glucocorticoids 98
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 97
Steroid-sparing Strategies: Other Combinations 97
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 97
Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease 97
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 97
Molecular mechanisms of respiratory virus-induced inflammation. 97
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 97
Degree of control of physician-diagnosed asthma and COPD in Italy. 96
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 96
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 96
Novel anti-inflammatory treatments for asthma and COPD 96
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 95
New insights into the molecular mechanisms of corticosteroids actions 95
null 95
Bronchial glomus tumor mimicking a COPD exacerbation 95
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 94
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 94
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 93
STAT2 activation in smokers and patients with chronic obstructive pulmonary disease 93
Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. 93
Telomere shortening in alveolar macrophages of smokers and COPD patients 93
High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD 93
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 93
Definition, clinical features, investigations and differential diagnosis in asthma 92
Gene-environment interactions in the development of chronic obstructive pulmonary disease 92
null 92
Mechanisms of respiratory virus-induced asthma exacerbations 92
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 92
New targets for drug development in asthma 91
Pharmacology of airway inflammation in asthma and COPD 91
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 91
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 91
null 91
Increased deposition of activated complement in peripheral lung vessels of smokers 91
null 91
Corticosteroidi, disodiocromoglicato e nedocromile nella terapia dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 90
Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma 90
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease 90
Targeting Th2 cells in asthmatic airways 90
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 90
New drugs targeting Th2 lymphocytes in asthma 90
null 90
Totale 10.815
Categoria #
all - tutte 90.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.040
Totale 104.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.079 1.009 149 153 740 295 600 405 564 353 529 177 105
2020/20213.532 309 328 155 480 165 397 109 419 60 424 438 248
2021/20222.572 61 287 199 218 74 94 99 163 93 235 267 782
2022/20232.622 351 61 78 324 375 457 69 245 361 25 183 93
2023/20241.107 148 173 53 30 87 139 27 47 23 37 42 301
2024/2025174 174 0 0 0 0 0 0 0 0 0 0 0
Totale 22.845